Leiomyosarcoma (LMS) is a type of soft tissue sarcoma — and a very rare type of cancer. Doctors often find LMS cancer in the uterus. But it can occur in any of your body’s smooth muscles. This cancer ...
A combination of the poly-ADP ribose polymerase (PARP) inhibitor olaparib and the chemotherapy temozolomide shows preliminary activity in advanced uterine leiomyosarcoma that has progressed on ...
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250)
FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) Study Uterine leiomyosarcoma (uLMS) is ...
The combination of Bavencio and gemcitabine showed promising efficacy and safety in certain patients with advanced leiomyosarcoma. Treatment with Bavencio (avelumab) and gemcitabine demonstrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results